Amfepramone (diethylpropion) is a sympathomimetic appetite suppressant that promotes catecholamine release to reduce hunger, used short-term as an adjunct in obesity management. Simson Pharma's Amfepramone reference standard supports compendial and controlled-substance-aligned testing for this weight-management therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amfepramone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
